Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
  • Press shift tab to select search category
    Loading...
  •  United States
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
    • UAE & Gulf
    • Saudi Arabia
  • Home
  • Company
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Science
      < Back
    • Science
    • Areas of Focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Responsibility
      < Back
    • Responsibility
    • Responsibility
    • Environment
    • People
    • Governance
    • Charitable Donations 
  • Patients
      < Back
    • Patients
    • Patients
    • Early Access Public Policy
  • Stories
  1. Home
  2. Untitled
  3. Financial Calendar events

H1 2023 results

Post navigation

Previous
Next

H1 2023 results

H1 2023 results

- 27 July 2023 - 0 mins read

Post navigation

Previous
Next
Share this on social media
  • Share on LinkedIn
  • Share on Facebook
  • Share on Email

Related Events

06 June 2023

Dividend payment date
26 October 2023

YTD 2023 Sales
02 June 2023

Ex-dividend date
31 May 2023

Annual shareholders meeting
09 February 2023

FY 2022 results
27 April 2023

Q1 2023 sales
24 May 2022

Annual Shareholders’ Meeting
31 May 2022

Ex-dividend date
02 June 2022

Dividend payment date
28 July 2022

H1 2022 results

IPN price

€167.50

 €2.40 (1.45%)

  • Media
  • Investors
  • Partnering
  • Contact us
  • Leadership
  • Responsibility
  • Patients
  • Stories
  • Compliance
  • U.S. State Pricing Disclosures
  • Vigilance Alert: Identity Theft
Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms of Use
  • Privacy
  • Consumer Health Data Privacy
  • Cookies
  • Your Privacy Choices

© Ipsen Biopharmaceuticals, Inc. All rights reserved - 2026

You are now leaving the Ipsen US website. To continue, please click on continue.

Continue